Claude

Know the Business

MetLife is a $49 billion global insurance and financial services conglomerate that makes money three ways: underwriting insurance risk (primarily group benefits and life), harvesting investment spreads on a $745 billion balance sheet, and increasingly, earning fees on third-party assets under management. The market likely underestimates how much the earnings mix is shifting toward capital-light fee income through the MIM/PineBridge expansion, while overestimating the downside from GAAP earnings volatility driven by derivative and market risk benefit marks that obscure stable underlying adjusted earnings of roughly $5.9 billion.

How This Business Actually Works

MetLife's economic engine runs on three interconnected cylinders that share one critical asset: its massive investment portfolio.

Premiums and float drive the core. MetLife collects $50 billion in annual premiums, primarily through Group Benefits (employer-sponsored life, dental, disability) and Retirement and Income Solutions (pension risk transfers, annuities). These premiums arrive before claims are paid, creating float that gets invested.

The investment spread is the real profit center. MetLife's general account portfolio – $351 billion in long-term investments, heavily weighted toward fixed income – generated $22.6 billion in net investment income in FY2025. The spread between what MetLife earns on this portfolio and what it credits to policyholders is the dominant driver of profitability. Variable investment income (private equity, real estate) adds upside volatility – $497 million in Q4 2025 alone from strong PE returns.

Fee-based income is the growth frontier. The December 2025 acquisition of PineBridge Investments brought MIM's combined AUM to $735 billion, making it a top-25 global institutional asset manager. This is capital-light revenue that does not require reserves or statutory capital.

Cost structure insight: The key expenses are policyholder benefits and claims ($50.3 billion), interest credited to policyholders ($9.0 billion), and operating expenses ($10.7 billion). MetLife targets a direct expense ratio of 12.1% for 2026 and 11.3% by 2029 – this is the lever management can actually control. The claims side is driven by mortality, morbidity, and interest rate assumptions that create GAAP volatility but are more stable on an adjusted basis.

The Playing Field

MetLife competes against a mix of diversified life insurers, pure-play group benefits specialists, and increasingly, asset managers. Its most relevant peers are Prudential Financial (PRU), Aflac (AFL), Principal Financial (PFG), Lincoln National (LNC), and Unum Group (UNM).

What the peer set reveals:

MetLife trades at the second-lowest P/E (15.7x) despite generating higher adjusted ROE (16% ex-notable items) than peers realize on GAAP. This discount reflects the market's difficulty seeing through MetLife's GAAP noise – derivative marks, MRB remeasurements, and LDTI accounting all distort reported earnings. Aflac commands a premium valuation because its supplemental insurance model in Japan is simpler, higher-margin (21% profit margin vs. MetLife's 4.4%), and less capital-intensive. Prudential trades at a deep discount (9.7x) for similar reasons to MetLife – complexity and GAAP opacity.

MetLife's competitive advantage is scale in Group Benefits. It serves 80% of Fortune 500 companies and is three times larger than its closest competitor. This creates stickiness: switching group benefits providers is operationally painful for large employers. The disadvantage is that MetLife's diversification – six segments across dozens of countries – makes the company harder to understand and value, which compresses the multiple.

Lincoln National at 0.89x book is the distressed peer; it signals what happens when an insurer gets its variable annuity guarantees wrong. MetLife shed much of that legacy risk through reinsurance transactions.

Is This Business Cyclical?

Life insurance is less cyclical than property and casualty, but MetLife is not immune. The cycle hits through three channels: interest rates, investment returns, and employment.

The key insight from this chart: Operating cash flow has been remarkably stable and steadily growing ($11.6 billion to $18.1 billion over seven years) even as GAAP net income has gyrated wildly ($1.6 billion to $6.9 billion). This divergence is the single most important thing to understand about MetLife. The cash flow stability reflects the underlying economics; the net income volatility reflects accounting.

Interest rates are the primary cyclical exposure. MetLife benefits from higher rates because it earns more on its investment portfolio while crediting rates to policyholders adjust with a lag. A 50bp decline in rates would reduce adjusted earnings by $38 million in year one, rising to $138 million by year three. Conversely, a 50bp rise adds $44 million to $146 million. The asymmetry is modest – MetLife has hedged well with long-duration receive-fixed swaps.

Variable investment income creates quarterly volatility. Private equity and real estate returns swung from $195 million (Q2 2025, weak PE quarter) to $497 million (Q4 2025, strong PE quarter). Management guides to roughly $1.6 billion annually but the quarterly swings dominate earnings surprise.

Employment cycles affect Group Benefits directly – premiums scale with employer headcount and compensation. This makes MetLife a mild beneficiary of a tight labor market and vulnerable to recession-driven layoffs.

COVID stress test: FY2020 proved MetLife's resilience. Despite elevated mortality claims and rate cuts to near-zero, net income declined only 8% and operating cash flow barely budged. The diversification across geographies and product types provided genuine ballast.

The Metrics That Actually Matter

Adjusted earnings, not GAAP net income, is the only useful measure of MetLife's profitability. GAAP includes derivative mark-to-market swings, MRB remeasurements, and LDTI assumption updates that have nothing to do with the business's cash-generating ability. MetLife's adjusted earnings have grown from $5.5 billion (FY2023) to $5.9 billion (FY2025) – steady 4% annual growth that the volatile GAAP numbers completely obscure.

The direct expense ratio is the purest measure of management execution because it is the one thing the CEO team can control quarter-to-quarter. MetLife has committed to reducing it from 12.2% to 11.3% over five years – a 90bp improvement that, applied to a ~$50 billion revenue base, implies roughly $450 million of incremental pre-tax earnings purely from efficiency.

Free cash flow ratio (65-75% of adjusted earnings) tells you how much of the reported earnings is actually extractable from the regulated insurance subsidiaries and available to the holding company for dividends, buybacks, and debt service. MetLife beat this target in FY2025 and guides to roughly $25 billion of cumulative free cash flow over 2025-2029.

Variable investment income is what creates quarterly surprise. Track private equity return benchmarks and commercial real estate values to anticipate whether MetLife will beat or miss. In strong PE quarters, MetLife looks like a hero; in weak ones, the headline misses consensus despite stable underwriting.

What I'd Tell a Young Analyst

Ignore GAAP net income. It will mislead you every quarter. The gap between MetLife's GAAP earnings ($3.2 billion) and adjusted earnings ($5.9 billion) is not management spin – it reflects real accounting distortions from derivatives, MRB remeasurements, and LDTI that create noise around a stable underlying business. Your job is to assess whether the adjusted earnings are real, sustainable, and growing. They are.

Watch the Group Benefits loss ratio and expense ratio. These two numbers tell you whether the core franchise is healthy. Group Benefits is the franchise – the employer relationships, the recurring premium streams, the enrollment stickiness. Everything else is either cyclical (RIS/pension risk transfers), interest-rate-dependent (Corporate and Other), or optionality (MIM, international growth).

The PineBridge acquisition is the most important strategic bet in years. MIM at $735 billion AUM is now MetLife's fourth growth priority and its most capital-efficient business. If MIM can grow third-party AUM at 5-10% annually, it shifts the earnings mix toward fee income and could earn MetLife a higher multiple over time. But asset management is competitive and cyclical in its own way – AUM-linked fees decline in bear markets.

The real risk is not a recession; it is prolonged low rates combined with rising long-term care liabilities. MetLife has hedged near-term rate risk effectively, but a sustained decline in rates compresses spreads across the entire book and cannot be fully hedged. Long-term care remains a legacy tail risk in Corporate and Other. Management has substantially reduced universal life exposure through reinsurance, but long-term care reserves depend on assumptions about morbidity, lapse, and discount rates that are inherently uncertain.

If MetLife achieves its New Frontier targets – double-digit EPS growth, 15-17% adjusted ROE, 11.3% expense ratio by 2029 – the stock is meaningfully undervalued at 8x forward earnings. The question is whether the market will ever give a complex global insurer credit for consistent execution, or whether the GAAP noise and balance sheet opacity will keep the multiple permanently compressed.